Transfusion-Transmitted Hepatitis A Virus, France, 2018

por Lefeuvre, Caroline, Lefort, Caroline, Boyer, Françoise, Le Cam, Sophie, Mouna, Lina, Roque-Afonso, Anne-Marie, Le Guillou-Guillemette, Hélène, Mahieu, Rafaël
Publicado 2022

P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE...

por Bose, Prithviraj, Mohan, Sanjay, Oh, Stephen, Gotlib, Jason, Ritchie, Ellen, Shimomura, Taizo, Ali, Haris, Boyer, Francoise, Guglielmelli, Paola, Hunter, Anthony M., Lamothe, Betty, Cui, Yi, Seguy, Francis, Mcbride, Amanda, Palandri, Francesca, Takeuchi, Masahiro, Kiladjian, Jean-Jacques
Publicado 2023

Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis

por Lemoine, Sandrine, Mornet, Clelia, Quintin-Roue, Isabelle, Rousselet, MarieChristine, Cottin, Laurane, Georgeais, Aurélie, Dubouis, Ludovic, Boyer, Françoise, Orvain, Corentin, Caillon, Clara, Renard, Maxime, Le Brun, Valoris, Le Clech, Lenaig, Ianotto, Jean-Christophe, Génin, Emmanuelle, Burroni, Barbara, Ugo, Valérie, Paz, Damien Luque, Lippert, Eric
Publicado 2022

S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIM...

por Mascarenhas, John, Jain, Tania, Otoukesh, Salman, Gerds, Aaron T., Lucchesi, Alessandro, Romina Sosa, Iberia, Laribi, Kamel, Mishchenko, Elena, Radinoff, Atanas, Benevolo, Giulia, Vannucchi, Alessandro M., Boyer, Francoise, Quittet, Philippe, Radsak, Markus, Machet, Antoine, Bose, Prithviraj, Huang, Zhuying, Qamoos, Hope, Mcgreivy, Jesse, Rothbaum, Wayne P., Verstovsek, Srdan, Passamonti, Francesco
Publicado 2023

Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10(9)/L to <100 × 10(9)/L) at baseline: the final analysis of EXPAND

por Guglielmelli, Paola, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Duan, Minghui, Meng, Haitao, Pan, Ling, He, Guangsheng, Verstovsek, Srdan, Boyer, Françoise, Barraco, Fiorenza, Niederwieser, Dietger, Pungolino, Ester, Liberati, Anna Marina, Harrison, Claire, Roussou, Pantelia, Wroclawska, Monika, Karumanchi, Divyadeep, Sinclair, Karen, te Boekhorst, Peter A.W., Gisslinger, Heinz
Publicado 2022

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

por Sureau, Léa, Buors, Caroline, Ianotto, Jean-Christophe, Boyer, Françoise, Tanguy-Schmidt, Aline, Roy, Lydia, Cayssials, Emilie, Cailly, Laura, Chomel, Jean-Claude, Chauveau, Aurélie, Orvain, Corentin, Mansier, Olivier, Ranta, Dana, Robles, Margot, Gyan, Emmanuel, Hérault, Olivier, Nimubona, Stanislas, Marchand, Tony, Lippert, Eric, Riou, Jérémie, Ugo, Valérie, Luque Paz, Damien
Publicado 2022

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups

por Robin, Marie, Porcher, Raphael, Orvain, Corentin, Bay, Jacques-Olivier, Barraco, Fiorenza, Huynh, Anne, Charbonnier, Amandine, Forcade, Edouard, Chantepie, Sylvain, Bulabois, Claude, Yakoub-Agha, Ibrahim, Detrait, Marie, Michonneau, David, Turlure, Pascal, Raus, Nicole, Boyer, Françoise, Suarez, Felipe, Vincent, Laure, Guyen, Stéphanie N., Cornillon, Jérôme, Villate, Alban, Dupriez, Brigitte, Cassinat, Bruno, Rolland, Valérie, Schlageter, Marie Hélène, Socié, Gérard, Kiladjian, Jean-Jacques
Publicado 2021